Penny Stock to Buy #4 – SuperGen (SUPG)
Pharmaceutical company SuperGen (NASDAQ: SUPG) is involved in the discovery and development of therapies to treat cancer patients. The company takes products already developed by other companies and applies additional developmental effort to expand sales and advance the products clinically toward approval for marketing.
SUPG stock has climbed 19% since last June. In its latest income statement, the company reported a net profit margin of 31%. Earnings wise, SuperGen reported a quarterly earnings growth of 18%, year-over-year, in its last income statement.